Evaluation of Fluid Tau Species as Surrogates for Tau PET in Alzheimer’s Disease
Personalized briefing
Discovery of the day · Neurology
Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer’s disease
Dear Hassna chourri, this is your personalized scientific intelligence briefing — curated for your work in Neurology.
Key finding
Medicine · Neurology
Discovery of the day
This study systematically evaluated multiple cerebrospinal fluid (CSF) and plasma tau species as potential surrogates for tau positron emission tomography (PET) in Alzheimer’s disease, from prodromal to moderate stages. The researchers found that CSF C2N-eMTBR-tau243, MTBR/243-254, p-tau205, and p-tau217 exhibited the strongest correlations with [18F]GTP1 tau PET standardized uptake value ratios, with plasma p-tau181 and p-tau217 showing similar correlation rankings to their CSF counterparts. For a neuroscience student researching neurodevelopmental disorders, this work provides a methodological framework for validating fluid biomarkers that could be adapted to study tau pathology in neurodevelopmental conditions where PET access is limited, potentially enabling more accessible longitudinal monitoring of tau-related processes in disorders such as autism spectrum disorder or intellectual disability.
Novelty
85%
Rigor
91%
Significance
92%
Validity
87%
Clarity
93%
Advertisement
ScientificChina — verified Chinese lab & medical equipment suppliers, direct. Browse suppliers →
Your briefing is personalized based on your selected fields, keywords, and research interests.
